BODYSCAPES, INC. – Trademark Portfolio

Entity Type: 03

BODYSCAPES, INC. has 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). Notable registered marks include ONE 2 ONE BODYSCAPES. The portfolio includes 1 registered trademark. Filings span 3 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 41 (Education & Entertainment). This trademark owner is based in NEW YORK, NY.

20 WEST 22ND STREET

NEW YORK, NY 10001

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

BODYSCAPES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (2 filings)

Advertising; business management; business administration; office functions

41
Education & Entertainment (2 filings)

Education; providing of training; entertainment; sporting and cultural activities

25
Clothing (1 filing)

Clothing, footwear, headgear

Frequently Asked Questions

How many trademarks does BODYSCAPES, INC. have?

BODYSCAPES, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 2 cancelled.

What trademark classes does BODYSCAPES, INC. file in?

BODYSCAPES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 25 (Clothing). Class 35 covers advertising; business management; business administration; office functions.

What are BODYSCAPES, INC.'s most well-known trademarks?

BODYSCAPES, INC.'s registered trademark portfolio includes well-known marks such as ONE 2 ONE BODYSCAPES. These are among 1 currently registered trademark in the portfolio.

What is BODYSCAPES, INC.'s trademark registration success rate?

BODYSCAPES, INC. has a 20% trademark registration rate, with 1 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.